Get started
BASILEA PHARM.NA SF 1BASILEA PHARM.NA SF 1BASILEA PHARM.NA SF 1

BASILEA PHARM.NA SF 1

No trades
See on Supercharts
Overview
Financials News Discussions Forecast Seasonals

PK5 chart


Full chart

PK5 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪627.89 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
8.1
Basic EPS (TTM)
6.8 EUR
Net income (FY)
‪82.53 M‬ EUR
Revenue (FY)
‪221.81 M‬ EUR
Shares float
‪11.26 M‬
Beta (1Y)
1.20

Employees


Employees (FY)
164
Change (1Y)
+17 +11.56%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About BASILEA N


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
David Veitch
Website
basilea.com
Headquarters
Allschwil
Founded
2000
ISIN
CH0011432447
FIGI
BBG000N5LWX2
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland.

Check out other big names from the same industry as PK5.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PK5 news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BASILEA PHARM.NA SF 1 stocks are traded under the ticker PK5.
We've gathered analysts' opinions on BASILEA PHARM.NA SF 1 future price: according to them, PK5 price has a max estimate of 107.10 EUR and a min estimate of 65.01 EUR. Watch PK5 chart and read a more detailed BASILEA PHARM.NA SF 1 stock forecast: see what analysts think of BASILEA PHARM.NA SF 1 and suggest that you do with its stocks.
PK5 reached its all-time high on Apr 2, 2007 with the price of 176.5 EUR, and its all-time low was 23.7 EUR and was reached on Nov 23, 2011. View more price dynamics on PK5 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track BASILEA PHARM.NA SF 1 financials in yearly and quarterly reports right on TradingView.
BASILEA PHARM.NA SF 1 is going to release the next earnings report on Aug 19, 2025. Keep track of upcoming events with our Earnings Calendar.
PK5 earnings for the last half-year are 5.00 EUR per share, whereas the estimation was 3.45 EUR, resulting in a 45.06% surprise. The estimated earnings for the next half-year are 2.17 EUR per share. See more details about BASILEA PHARM.NA SF 1 earnings.
BASILEA PHARM.NA SF 1 revenue for the last half-year amounts to ‪140.72 M‬ EUR, despite the estimated figure of ‪135.08 M‬ EUR. In the next half-year revenue is expected to reach ‪102.82 M‬ EUR.
PK5 net income for the last half-year is ‪60.47 M‬ EUR, while the previous report showed ‪21.53 M‬ EUR of net income which accounts for 180.82% change. Track more BASILEA PHARM.NA SF 1 financial stats to get the full picture.
No, PK5 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 13, 2025, the company has 164 employees. See our rating of the largest employees — is BASILEA PHARM.NA SF 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BASILEA PHARM.NA SF 1 EBITDA is ‪68.83 M‬ EUR, and current EBITDA margin is 31.03%. See more stats in BASILEA PHARM.NA SF 1 financial statements.
Like other stocks, PK5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BASILEA PHARM.NA SF 1 stock right from TradingView charts — choose your broker and connect to your account.